Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
Journal
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 16 (9), 1533-1546, 2021-09
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360861710919754880
-
- ISSN
- 15560864
-
- Data Source
-
- Crossref